The tumor microenvironment and strategies to improve drug distribution
about
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesDormancy of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia.Stress-induced cleavage of Myc promotes cancer cell survivalIn vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer.5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors.Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.3D Cell Culture in a Self-Assembled Nanofiber EnvironmentInfluence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer ModelAnticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models.Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.Pulsation-limited oxygen diffusion in the tumour microenvironment.Advances in targeting strategies for nanoparticles in cancer imaging and therapy.Influence of oxygen partial pressure on the characteristics of human hepatocarcinoma cells.Effects of chronic exposure to acidic environment on the response of tumor cells to radiation.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.The Linkage between Breast Cancer, Hypoxia, and Adipose Tissue.Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models.Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.Cellular processing of gold nanoparticles: CE-ICP-MS evidence for the speciation changes in human cytosol.Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins.Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.(99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiationLiposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Q26799981-1311B35B-A6E4-437C-B199-810BA2897642Q26991991-425775F1-4444-45DA-9A97-C5F85FE28674Q30436995-58BDC201-D67E-49D1-82FA-52BA440B9EDEQ33588071-35C2902B-FD8C-4265-B4C8-A50F0653CF3BQ33605281-F05C2736-B45A-40BA-B11F-BDEA4B428117Q34044642-3805C211-3FC2-4763-9D22-A0E8FB68F0E3Q35768413-74E80485-C5F8-4ACE-A23B-6627060626F5Q36134636-8D8C8711-0291-4972-A3F4-B117A14A20E1Q36262935-EC384502-5B8A-49A7-8206-CCA64CA239CBQ36352817-39890AE7-82D0-4D2C-B2B0-29407E4A6140Q36706902-FAF3C785-1459-4C1F-9498-42D4220DEDB4Q37417622-43A11B1D-F198-4F6A-B8E6-91ECADBD2684Q37550203-43E2E000-F3FA-46B1-BA5F-BD879B1D9247Q38255901-CA40ECDC-C67D-4157-9E03-F8BCD63A2FE2Q38715885-E857AF63-2577-4749-BBCF-BB39E9CB5680Q38758225-432547C1-F184-44B2-89DA-40564DFEFF1FQ38776676-1B875310-15A6-4DB0-B645-DFDB4308658AQ38848404-3F2906C6-A85F-4B5C-9197-6CF2F7CAE833Q42367956-690A03EB-BA05-4788-A956-0C11D0E8F136Q44178469-69D82492-6960-4A70-82CE-127F3CAD7152Q45070718-FAA5D8A6-2EAD-433D-A147-E3011505E9E5Q46260618-D1DFF855-E08B-4E13-98C2-5F9AF715BB7CQ47229193-F4E085EF-1440-4FC1-BF41-F2891F164979Q47385578-621FE5A1-D860-4B09-AA54-788EC3F0004DQ52948537-38DCFA99-07B3-40DB-B04A-2D507A83267CQ58729843-29DA68B5-304E-47AA-A266-7CE368954D8CQ59133970-9B4C5D62-BCA6-4B49-A3AF-97C585F6635E
P2860
The tumor microenvironment and strategies to improve drug distribution
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The tumor microenvironment and strategies to improve drug distribution
@ast
The tumor microenvironment and strategies to improve drug distribution
@en
The tumor microenvironment and strategies to improve drug distribution
@nl
type
label
The tumor microenvironment and strategies to improve drug distribution
@ast
The tumor microenvironment and strategies to improve drug distribution
@en
The tumor microenvironment and strategies to improve drug distribution
@nl
prefLabel
The tumor microenvironment and strategies to improve drug distribution
@ast
The tumor microenvironment and strategies to improve drug distribution
@en
The tumor microenvironment and strategies to improve drug distribution
@nl
P2093
P2860
P3181
P356
P1476
The tumor microenvironment and strategies to improve drug distribution
@en
P2093
Ian F Tannock
Jasdeep K Saggar
P2860
P3181
P356
10.3389/FONC.2013.00154
P407
P577
2013-01-01T00:00:00Z